Earnings Feed
Start Free
Home/Filings/4/0001209191-10-047762
4//SEC Filing

Stern Robert A 4

Accession 0001209191-10-047762

CIK 0001028318other
View on SEC.govCompany Profile

Filed

Sep 27, 8:00 PM ET

Accepted

Sep 28, 6:24 PM ET

Size

47.5 KB

Accession

0001209191-10-047762

Insider Transaction Report

Form 4
Period: 2010-09-27
MICRUS ENDOVASCULAR CORPMEND
Stern Robert A
President, COO and Secretary
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-09-27$10.35/sh−6,666$68,993→ 0 total
    Exercise: $13.05Exp: 2014-06-24→ Common Stock (6,666 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-09-27$17.77/sh−1,852$32,919→ 0 total
    Exercise: $5.63Exp: 2014-11-15→ Common Stock (1,852 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-09-27$14.21/sh−11,290$160,431→ 0 total
    Exercise: $9.19Exp: 2019-05-26→ Common Stock (11,290 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-09-27$17.77/sh−9,722$172,809→ 0 total
    Exercise: $5.63Exp: 2015-02-23→ Common Stock (9,722 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-09-27$5.89/sh−3,712$21,864→ 0 total
    Exercise: $17.51Exp: 2017-11-12→ Common Stock (3,712 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-09-27$14.21/sh−23,710$336,919→ 0 total
    Exercise: $9.19Exp: 2019-05-26→ Common Stock (23,710 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-09-27$13.35/sh−14,846$198,194→ 0 total
    Exercise: $10.05Exp: 2016-02-14→ Common Stock (14,846 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-09-27$17.77/sh−23,610$419,668→ 0 total
    Exercise: $5.63Exp: 2015-02-23→ Common Stock (23,610 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-09-27$2.40/sh−35,020$84,048→ 0 total
    Exercise: $21.00Exp: 2017-02-27→ Common Stock (35,020 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-09-27$2.40/sh−4,980$11,952→ 0 total
    Exercise: $21.00Exp: 2017-02-27→ Common Stock (4,980 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-09-27$17.77/sh−20,369$362,059→ 0 total
    Exercise: $5.63Exp: 2014-11-15→ Common Stock (20,369 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-09-27$13.35/sh−57,839$772,151→ 0 total
    Exercise: $10.05Exp: 2016-02-14→ Common Stock (57,839 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-09-27$22.25/sh−33,094$736,424→ 0 total
    Exercise: $1.15Exp: 2014-02-26→ Common Stock (33,094 underlying)
  • Disposition to Issuer

    Common Stock

    2010-09-27−10,924→ 0 total
  • Disposition to Issuer

    Common Stock

    2010-09-27−111→ 0 total(indirect: By Daughter)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-09-27$11.98/sh−2,606$31,220→ 0 total
    Exercise: $11.42Exp: 2018-05-14→ Common Stock (2,606 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-09-27$11.98/sh−22,394$268,280→ 0 total
    Exercise: $11.42Exp: 2018-05-14→ Common Stock (22,394 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-09-27$22.25/sh−40,405$899,112→ 0 total
    Exercise: $1.15Exp: 2014-02-26→ Common Stock (40,405 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-09-27$5.89/sh−21,288$125,386→ 0 total
    Exercise: $17.51Exp: 2017-11-12→ Common Stock (21,288 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-09-27$10.35/sh−2,222$22,998→ 0 total
    Exercise: $13.05Exp: 2014-06-24→ Common Stock (2,222 underlying)
Footnotes (3)
  • [F1]3,333 shares of common stock were purchased under Micrus Endovascular Corporation's 2005 Employee Stock Purchase Plan as follows: 1,111 shares on Septmber 30, 2009, 1,111 shares on March 31, 2010 and 1,111 shares on September 23, 2010.
  • [F2]Pursuant to the Agreement and Plan of Merger, dated as of July 11, 2010, between Micrus Endovascular Corporation, Johnson & Johnson and Cope Acquisition Corp., each share of common stock held by the reporting person was converted into the right to receive $23.40 in cash, without interest.
  • [F3]Pursuant to the Agreement and Plan of Merger, dated as of July 11, 2010, between Micrus Endovascular Corporation, Johnson & Johnson and Cope Acquisition Corp., this stock option was converted into the right to receive an amount in cash per share subject to the stock option equal to the excess of the per share merger consideration of $23.40 over the per share exercise price of such stock option, without interest.

Documents

1 file

Issuer

MICRUS ENDOVASCULAR CORP

CIK 0001028318

→
Entity typeother

Related Parties

1
  • filerCIK 0001325282

Filing Metadata

Form type
4
Filed
Sep 27, 8:00 PM ET
Accepted
Sep 28, 6:24 PM ET
Size
47.5 KB
View on SEC.gov